Outer Biosciences combines machine learning with living human skin

Outer Biosciences combines its YUNA automated assays, machine learning and full-thickness donated human skin that the company says remains viable for four weeks. The work was reported on August 21, 2026.

A closed loop is used: the model predicts candidates, they are tested in the tissue, and the results are fed back into the model.

Why it matters: this marks a shift from biotech models that use only public data toward proprietary human-tissue data and iterative wet-lab validation.

Protocol transparency, donor diversity, blinded replication, safety and clinical evidence are all needed. Throughput, candidate cadence and commercial performance are company claims, not peer-reviewed outcomes.